Table 2.

Intra- and postoperative clinical outcomes

	PIFB group (n = 49)	SALI group (n = 49)	P-value
Intraoperative sufentanil consumption (μg)	118 ± 32	76 ± 10	< 0.01
Postoperative sufentanil consumption (μg)	108 ± 30	62 ± 15	< 0.01
Parecoxib consumption (mg)	60 ± 20	120 ± 40	< 0.01
Time to extubation (h)	9.7 ± 3.5	2.7 ± 1.8	< 0.01
Time to drain removal (h)	33 ± 8	30 ± 9	0.41
Length of stay in the ICU (h)	27 ± 11	17 ± 5	< 0.05
Incidence of PONV (%)	5(10.2)	7(14.3)	0.54
Time to first feces (h)	42 ± 16	39 ± 11	0.43
Length of hospital stay (h)	208 ± 23	175 ± 15	< 0.05

P < 0.05 considered statistically significant